Skip to main content
Ingrid Skop

Ingrid Skop

Director of medical affairs of the Susan B. Anthony List

Nov 5, 2026

10:46
Can you go over some of the concerns that we have from what they released on October 7th?
10:52
Yes, absolutely.
10:53
There were some good things.
10:54
They did say that they were going to compare medical abortions to surgical abortions.
10:59
And that is something that the FDA has not done because study after study has shown us that women are more likely to have complications up to four times as often when they have a medical abortion compared to surgical abortion.
11:13
So we do need to know which method is safer because, again, they should never have approved a less safe method under accelerated approval regulations at the beginning.
11:24
They also said they are going to take the input from all stakeholders.

9 MINS LATER

20:10
You know, what impact you're seeing and, you know, where you hope we go from here.
10:17
Ingrid, do you want to just hit some of the highlights, the major points along the timeline that would be crucial for people to have in mind as we talk through then your analysis of the 2021 changes?
10:31
Yes, absolutely.
10:32
So mifepristone in conjunction with misoprostol for a medication abortion was approved by the FDA in the year 2000.
10:41
And we see there was much politicization involved.
10:45
They wanted to get this done in the waning days of the Clinton administration.
10:50
And so they used accelerated approval regulations.
10:53
That's not appropriate.

6 MINS LATER

16:47
Can you just explain what that means and why that's actually important that there is this standard for when an FDA approves a drug?
Lauren CanterberryCORRESPONDENT
21:36
Dr. Ingrid Skop is the vice president and director of medical affairs for the Charlotte Lozier Institute.
21:41
So it, it generally can happen on its own.
21:45
I would say the, the downside is that sometimes it's just really hard emotionally to wait.
Lauren CanterberryCORRESPONDENT
22:16
And now, a third option is gaining support, using the abortion drug mifepristone along with misoprostol.
22:23
There have been a number of studies that have looked at misoprostol versus mifepristone and misoprostol, and have documented slightly more efficacy with the combination drug.
Lauren CanterberryCORRESPONDENT
12:28
Skop said in rare cases, doctors may recommend delivering a baby early to protect the mother, but those decisions usually come after hospital admission and close monitoring.
12:39
If an emergency threatens my patient's life after the time of viability, then my job is to separate the child from the mother.
12:49
Ending the pregnancy will help the mother to begin to recover-
Lauren CanterberryCORRESPONDENT
13:11
No doctor has ever been sued for delivering a baby early to save a pregnant woman's life, but many have been sued over claims that they denied or delayed care due to pro-life laws.
13:22
No state requires that risk to be immediate, nor does any state require a doctor to be certain that she will die.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.